Simon Cawthorn

First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial

J Cuzick, JF Forbes, Rob Edwards et al. · The Lancet · 2002 · 742 citations

Breast Oncology, Preventive Medicine, Cancer Screening +10

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial

Jack Cuzick, Ivana Šestak, John Forbes et al. · The Lancet · 2013 · 578 citations · Full text

Breast Oncology, Medicine, Cancer Management +11

Long-Term Results of Tamoxifen Prophylaxis for Breast Cancer--96-Month Follow-up of the Randomized IBIS-I Trial

Jack Cuzick, JF Forbes, Ivana Šestak et al. · JNCI Journal of the National Cancer Institute · 2007 · 533 citations · Full text

Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial

Jack Cuzick, Ivana Šestak, Simon Cawthorn et al. · The Lancet Oncology · 2014 · 451 citations · Full text

Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study

Robert E. Coleman, Linda M. Banks, Samia I. Girgis et al. · The Lancet Oncology · 2007 · 424 citations

Bone Disease, Bone Biomarkers, Breast Oncology +12